Xuwei Guo 2025 Joint Meeting of the COSA ASM and IPOS Congress

Abstracts this author is presenting:

• Immune checkpoint inhibitors combined with targeted agents for the first-line treatment of unresectable hepatocellular carcinoma: a systematic review and meta-analysis — Afternoon tea, Poster session 1 & Exhibition